Maeve P. Smith

2.5k total citations
25 papers, 613 citations indexed

About

Maeve P. Smith is a scholar working on Pulmonary and Respiratory Medicine, Neurology and Epidemiology. According to data from OpenAlex, Maeve P. Smith has authored 25 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 7 papers in Neurology and 7 papers in Epidemiology. Recurrent topics in Maeve P. Smith's work include Cystic Fibrosis Research Advances (11 papers), Long-Term Effects of COVID-19 (7 papers) and Respiratory viral infections research (4 papers). Maeve P. Smith is often cited by papers focused on Cystic Fibrosis Research Advances (11 papers), Long-Term Effects of COVID-19 (7 papers) and Respiratory viral infections research (4 papers). Maeve P. Smith collaborates with scholars based in Canada, United Kingdom and Ireland. Maeve P. Smith's co-authors include Adam T. Hill, James D. Chalmers, John R. W. Govan, Brian J. McHugh, Burton L. Wise, Grace Y. Lam, Catherine Doherty, David C. Kilpatrick, Jennifer K Quint and Michael K. Stickland and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Scientific Reports and CHEST Journal.

In The Last Decade

Maeve P. Smith

22 papers receiving 594 citations

Peers

Countries citing papers authored by Maeve P. Smith

Since Specialization

Citations

This map shows the geographic impact of Maeve P. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maeve P. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maeve P. Smith more than expected).

Fields of papers citing papers by Maeve P. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maeve P. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maeve P. Smith. The network helps show where Maeve P. Smith may publish in the future.

Co-authorship network of co-authors of Maeve P. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Maeve P. Smith. A scholar is included among the top collaborators of Maeve P. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maeve P. Smith. Maeve P. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Factors associated with phenotypes of dyspnea in post-COVID-19 condition: a cross-sectional study 2024 ·Scientific Reports ·Maeve P. Smith, Heather Sharpe, Ronald W. Damant, Giovanni Ferrara, Rachel Lim, Michael K. Stickland, Grace Y. Lam	3
2	The Canadian Bronchiectasis and Nontuberculous Mycobacteria Registry: a study protocol 2024 ·ERJ Open Research ·Christina S. Thornton, (unknown), (unknown), Ranjani Somayaji, Swathi Purighalla, Sarah K. Brode, Theodore K. Marras, (unknown), Maeve P. Smith, Julie Jarand	0
3	Antibody responses in blood and saliva post COVID-19 bivalent booster do not reveal an Omicron BA.4/BA.5- specific response 2024 ·Frontiers in Immunology ·(unknown), Rebecca Lawlor, Maeve P. Smith, (unknown), (unknown), Andrew A. Lover, Dominique Alfandari, Peter H. Reinhart, Kathleen F. Arcaro, Barbara A. Osborne	0
4	Characterizing long-COVID brain fog: a retrospective cohort study 2023 ·Journal of Neurology ·Grace Y. Lam, Ronald W. Damant, Giovanni Ferrara, Rachel Lim, Michael K. Stickland, Natacha S. Ogando, Christopher Power, Maeve P. Smith	10
5	The effectiveness of pulmonary rehabilitation for Post-COVID symptoms: A rapid review of the literature 2022 ·Respiratory Medicine ·Lesley Soril, Ronald W. Damant, Grace Y. Lam, Maeve P. Smith, Jason Weatherald, Jean Bourbeau, Paul Hernandez, Michael K. Stickland	38
6	Reliability and validity of the post COVID-19 condition stigma questionnaire: a prospective cohort study 2022 ·EClinicalMedicine ·Ronald W. Damant, Liam Rourke, Ying Cui, Grace Y. Lam, Maeve P. Smith, Desi P. Fuhr, (unknown), Rhea Varughese, Cheryl R. Laratta, Angela Lau, Eric Wong, Michael K. Stickland, Giovanni Ferrara	13
7	Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls 2022 ·Frontiers in Physiology ·Rhys I. Beaudry, (unknown), Rhea Varughese, (unknown), Desi P. Fuhr, Ronald W. Damant, Giovanni Ferrara, Grace Y. Lam, Maeve P. Smith, Michael K. Stickland	23
8	Reduced Exercise Tolerance in Long-COVID Patients 2021 ·Rhea Varughese, Grace Y. Lam, (unknown), (unknown), Eric Wong, A. Dean Befus, Ronald W. Damant, Giovanni Ferrara, Maeve P. Smith, Michael K. Stickland	4
9	Association between vitamin D status in early pregnancy and atopy in offspring in a vitamin D deplete cohort 2019 ·Irish Journal of Medical Science (1971 -) ·Maeve P. Smith, Eileen C. O’Brien, Goiuri Alberdi, Aisling A. Geraghty, Mark Kilbane, Malachi J. McKenna, Fionnuala M. McAuliffe	8
10	Validation of the Incremental Shuttle Walk Test as a Clinical End Point in Bronchiectasis 2018 ·CHEST Journal ·(unknown), Maeve P. Smith, Pallavi Bedi, (unknown), Andrea Clarke, Leandro Cruz Mantoani, Roberto Rabinovich, Adriano G. Rossi, Adam T. Hill	6
11	The use of fructosamine in cystic fibrosis-related diabetes (CFRD) screening 2017 ·Journal of Cystic Fibrosis ·Grace Y. Lam, (unknown), (unknown), Karina Rodríguez-Capote, Trefor Higgins, (unknown), (unknown), Maeve P. Smith, Neil E. Brown, (unknown), Mathew P. Estey	12
12	Diagnosis and management of bronchiectasis 2017 ·Canadian Medical Association Journal ·Maeve P. Smith	25
13	A prospective cohort study of the use of domiciliary intravenous antibiotics in bronchiectasis 2014 ·npj Primary Care Respiratory Medicine ·Pallavi Bedi, Manjit Sidhu, (unknown), James D. Chalmers, Maeve P. Smith, Kim Turnbull, (unknown), Jenny Scott, Adam T. Hill	15
14	Mannose-binding lectin deficiency and disease severity in non-cystic fibrosis bronchiectasis: a prospective study 2013 ·The Lancet Respiratory Medicine ·James D. Chalmers, Brian J. McHugh, Catherine Doherty, Maeve P. Smith, John R. W. Govan, David C. Kilpatrick, Adam T. Hill	68
15	Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non–Cystic Fibrosis Bronchiectasis 2012 ·American Journal of Respiratory and Critical Care Medicine ·James D. Chalmers, Maeve P. Smith, Brian J. McHugh, (unknown), John R. W. Govan, Adam T. Hill	290
16	Eight-weekly intravenous antibiotics is beneficial in severe bronchiectasis 2012 ·QJM ·P. Mandal, Manjit Sidhu, (unknown), James D. Chalmers, Maeve P. Smith, Kim Turnbull, Jenny Scott, Adam T. Hill	25
17	Evaluating Success of Therapy for Bronchiectasis 2012 ·Clinics in Chest Medicine ·Maeve P. Smith, Adam T. Hill	19
18	Lactate is an independent marker of severity in hospitalised patients with community-acquired pneumonia 2011 ·European Respiratory Journal ·James D. Chalmers, Aran Singanayagam, Ahsan R. Akram, Pallavi Mandal, Gourab Choudhury, Maeve P. Smith, Adam T. Hill	1
19	S107 The influence of viral symptoms in infective exacerbations of non-cystic fibrosis bronchiectasis 2011 ·Thorax ·Maeve P. Smith, (unknown), John R. W. Govan, Kate Templeton, Adam T. Hill	1
20	An infant presenting with skin colour changes 2005 ·Clinical and Experimental Dermatology ·Maeve P. Smith, O. M. V. Schofield	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact